Skip to main content
Livermore
Livermore
ZHEN

D. E. Shaw & Co., Inc.

SEC CIK
0001009207
Latest filing
Aug 14, 2026

FULC holding history

Fulcrum Therapeutics, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

FULC overviewAll 13F holders of FULCFull Q2 2026 holdings

Shares (Q2 2026)
3,044,385
Value
$11.1M
% of portfolio
<0.1%
Quarters held
20
Since Q3 2021
Holdings of FULC by D. E. Shaw & Co., Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20263,044,385$11.1M<0.1%+1,421,104+87.5%AddedHolders
Q1 20261,623,281$12.5M<0.1%−290,474−15.2%ReducedHolders
Q4 20251,913,755$21.6M<0.1%+464,332+32.0%AddedHolders
Q3 20251,449,423$13.3M<0.1%+272,712+23.2%AddedHolders
Q2 20251,176,711$8.10M<0.1%+596,050+102.7%AddedHolders
Q1 2025580,661$1.67M<0.1%−2,542−0.4%ReducedHolders
Q4 2024583,203$2.74M<0.1%−174,528−23.0%ReducedHolders
Q3 2024757,731$2.71M<0.1%+165,946+28.0%AddedHolders
Q2 2024591,785$3.67M<0.1%−33,391−5.3%ReducedHolders
Q1 2024625,176$5.90M<0.1%+127,497+25.6%AddedHolders
Q4 2023497,679$3.36M<0.1%+276,415+124.9%AddedHolders
Q3 2023221,264$982.4K<0.1%+75,042+51.3%AddedHolders
Q2 2023146,222$482.5K<0.1%+130,899+854.3%AddedHolders
Q1 202315,323$43.7K<0.1%−160,823−91.3%ReducedHolders
Q4 2022176,146$1.28M<0.1%+93,807+113.9%AddedHolders
Q3 202282,339$666.0K<0.1%−57,143−41.0%ReducedHolders
Q2 2022139,482$683.0K<0.1%−407,922−74.5%ReducedHolders
Q1 2022547,404$12.9M<0.1%−304,744−35.8%ReducedHolders
Q4 2021852,148$15.1M<0.1%+54,047+6.8%AddedHolders
Q3 2021798,101$22.5M<0.1%+798,101NewHolders